373
Views
4
CrossRef citations to date
0
Altmetric
Osteoporosis

Correlation between zoledronic acid infusion and repeat vertebroplasty surgery in osteoporotic patients

, , , , , , & show all
Pages 921-927 | Received 06 Dec 2015, Accepted 03 Feb 2016, Published online: 23 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chen Shi, Mi Zhang, An-Yuan Cheng & Zi-Feng Huang. (2018) Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly. Clinical Interventions in Aging 13, pages 853-861.
Read now

Articles from other publishers (3)

Binbin Tang, Hanbing Zeng, Shengjia Hu, Kang Liu, Lianguo Wu & Xiaolin Shi. (2022) Percutaneous Vertebroplasty Combined with Zoledronic Acid in Treatment and Prevention of Osteoporotic Vertebral Compression Fractures: A Systematic Review and Meta-Analysis of Comparative Studies. World Neurosurgery 157, pages 75-87.
Crossref
Peng Tian, Yue Liu, Zhi-jun Li, Gui-jun Xu & Xin-long Ma. (2021) Zoledronic Acid in Osteoporotic Vertebral Compression Fractures Treated With Percutaneous Kyphoplasty: A Meta-Analysis. Frontiers in Surgery 8.
Crossref
S Yu Vorotnikova & E A Pigarova. (2016) ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS AND OTHER SKELETAL DISORDERS. Osteoporosis and Bone Diseases 19:3, pages 23-27.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.